… ‐controlled trial of the once‐daily GLP‐1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a …
… if no plasma glucose measurement was available); local tolerability at injection site; allergic … Korean patients (the remainder were of Chinese or Indian origin), looked at liraglutide add-…..... Read More